Kimberly R Lockett
Examiner (ID: 6478, Phone: (571)272-2067 , Office: P/2837 )
Most Active Art Unit | 2837 |
Art Unit(s) | 2837, 2832, 2107 |
Total Applications | 2779 |
Issued Applications | 2301 |
Pending Applications | 126 |
Abandoned Applications | 351 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7373134
[patent_doc_number] => 20040006775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => 'Screening systems and methods for identifying modulators of xenobiotic matabolism'
[patent_app_type] => new
[patent_app_number] => 10/380555
[patent_app_country] => US
[patent_app_date] => 2003-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10242
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0006/20040006775.pdf
[firstpage_image] =>[orig_patent_app_number] => 10380555
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/380555 | Screening systems and methods for identifying modulators of xenobiotic matabolism | Jul 24, 2003 | Abandoned |
Array
(
[id] => 7216189
[patent_doc_number] => 20040071675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Vector system'
[patent_app_type] => new
[patent_app_number] => 10/429608
[patent_app_country] => US
[patent_app_date] => 2003-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 27264
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10429608
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/429608 | Vector system | May 4, 2003 | Abandoned |
Array
(
[id] => 7395197
[patent_doc_number] => 20040018178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-29
[patent_title] => 'Stem cell-derived endothelial cells modified to disrupt tumor angiogenesis'
[patent_app_type] => new
[patent_app_number] => 10/348359
[patent_app_country] => US
[patent_app_date] => 2003-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10598
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20040018178.pdf
[firstpage_image] =>[orig_patent_app_number] => 10348359
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/348359 | Stem cell-derived endothelial cells modified to disrupt tumor angiogenesis | Jan 21, 2003 | Abandoned |
Array
(
[id] => 6851005
[patent_doc_number] => 20030143208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Oxidative stress-resistant cell lines and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 10/337049
[patent_app_country] => US
[patent_app_date] => 2003-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8186
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20030143208.pdf
[firstpage_image] =>[orig_patent_app_number] => 10337049
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/337049 | Oxidative stress-resistant cell lines and methods of use thereof | Jan 5, 2003 | Abandoned |
Array
(
[id] => 6639355
[patent_doc_number] => 20030212027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Vaccine formulations and methods for immunizing an individual against shed antigen specific B cells'
[patent_app_type] => new
[patent_app_number] => 10/336210
[patent_app_country] => US
[patent_app_date] => 2003-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13809
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20030212027.pdf
[firstpage_image] =>[orig_patent_app_number] => 10336210
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/336210 | Vaccine formulations and methods for immunizing an individual against shed antigen specific B cells | Jan 2, 2003 | Abandoned |
Array
(
[id] => 6760736
[patent_doc_number] => 20030124097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Method to improve the safety of gene therapy'
[patent_app_type] => new
[patent_app_number] => 10/310991
[patent_app_country] => US
[patent_app_date] => 2002-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8355
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20030124097.pdf
[firstpage_image] =>[orig_patent_app_number] => 10310991
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/310991 | Method to improve the safety of gene therapy | Dec 5, 2002 | Abandoned |
Array
(
[id] => 6669425
[patent_doc_number] => 20030114409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Facilitation of RNA interference'
[patent_app_type] => new
[patent_app_number] => 10/295809
[patent_app_country] => US
[patent_app_date] => 2002-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14388
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20030114409.pdf
[firstpage_image] =>[orig_patent_app_number] => 10295809
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/295809 | Facilitation of RNA interference | Nov 14, 2002 | Abandoned |
Array
(
[id] => 6869484
[patent_doc_number] => 20030082173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Lymphocyte surface receptor that binds CAML and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 10/293816
[patent_app_country] => US
[patent_app_date] => 2002-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 26850
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082173.pdf
[firstpage_image] =>[orig_patent_app_number] => 10293816
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/293816 | Lymphocyte surface receptor that binds CAML and methods of use thereof | Nov 11, 2002 | Abandoned |
Array
(
[id] => 6668929
[patent_doc_number] => 20030113913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Method of enhancing self renewal of stem cells and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/274054
[patent_app_country] => US
[patent_app_date] => 2002-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7191
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20030113913.pdf
[firstpage_image] =>[orig_patent_app_number] => 10274054
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/274054 | Method of enhancing self renewal of stem cells and uses thereof | Oct 20, 2002 | Abandoned |
Array
(
[id] => 7312763
[patent_doc_number] => 20040033486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-19
[patent_title] => 'M cell directed vaccines'
[patent_app_type] => new
[patent_app_number] => 10/169492
[patent_app_country] => US
[patent_app_date] => 2002-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11307
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20040033486.pdf
[firstpage_image] =>[orig_patent_app_number] => 10169492
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/169492 | M cell directed vaccines | Oct 20, 2002 | Abandoned |
Array
(
[id] => 524233
[patent_doc_number] => 07186879
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-06
[patent_title] => 'Screening systems and methods for identifying modulators of xenobiotic metabolism'
[patent_app_type] => utility
[patent_app_number] => 10/268822
[patent_app_country] => US
[patent_app_date] => 2002-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 27
[patent_no_of_words] => 16707
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/186/07186879.pdf
[firstpage_image] =>[orig_patent_app_number] => 10268822
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/268822 | Screening systems and methods for identifying modulators of xenobiotic metabolism | Oct 9, 2002 | Issued |
Array
(
[id] => 7036724
[patent_doc_number] => 20050034183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Non-human animal model for analysis of the original and therapy of organ fibrosis'
[patent_app_type] => utility
[patent_app_number] => 10/490885
[patent_app_country] => US
[patent_app_date] => 2002-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3402
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20050034183.pdf
[firstpage_image] =>[orig_patent_app_number] => 10490885
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/490885 | Non-human animal model for analysis of the original and therapy of organ fibrosis | Sep 26, 2002 | Abandoned |
Array
(
[id] => 6658027
[patent_doc_number] => 20030078228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Fas Ligand'
[patent_app_type] => new
[patent_app_number] => 10/252821
[patent_app_country] => US
[patent_app_date] => 2002-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7429
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20030078228.pdf
[firstpage_image] =>[orig_patent_app_number] => 10252821
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/252821 | Fas Ligand | Sep 23, 2002 | Abandoned |
10/110731 | Lymphocytes, a process for preparing the same and their use in therapeutics | Sep 15, 2002 | Abandoned |
Array
(
[id] => 6773835
[patent_doc_number] => 20030017173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Arrestable therapeutic viral agent'
[patent_app_type] => new
[patent_app_number] => 10/242827
[patent_app_country] => US
[patent_app_date] => 2002-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4006
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20030017173.pdf
[firstpage_image] =>[orig_patent_app_number] => 10242827
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/242827 | Arrestable therapeutic viral agent | Sep 12, 2002 | Abandoned |
Array
(
[id] => 6698328
[patent_doc_number] => 20030110522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Generation of transgenic mouse models for the development of prostate cancer using regulatory regions of the PSP94 gene'
[patent_app_type] => new
[patent_app_number] => 10/231773
[patent_app_country] => US
[patent_app_date] => 2002-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 14571
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20030110522.pdf
[firstpage_image] =>[orig_patent_app_number] => 10231773
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/231773 | Generation of transgenic mouse models for the development of prostate cancer using regulatory regions of the PSP94 gene | Aug 29, 2002 | Abandoned |
Array
(
[id] => 732934
[patent_doc_number] => 07037903
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-02
[patent_title] => 'Method for using thymosin β-10 for gene therapy of solid malignant tumors'
[patent_app_type] => utility
[patent_app_number] => 10/231845
[patent_app_country] => US
[patent_app_date] => 2002-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6239
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/037/07037903.pdf
[firstpage_image] =>[orig_patent_app_number] => 10231845
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/231845 | Method for using thymosin β-10 for gene therapy of solid malignant tumors | Aug 29, 2002 | Issued |
Array
(
[id] => 6675000
[patent_doc_number] => 20030060603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-27
[patent_title] => 'Antibodies generated against polypeptide targets expressed from polynucleotide administration'
[patent_app_type] => new
[patent_app_number] => 10/232777
[patent_app_country] => US
[patent_app_date] => 2002-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10838
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20030060603.pdf
[firstpage_image] =>[orig_patent_app_number] => 10232777
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/232777 | Antibodies generated against polypeptide targets expressed from polynucleotide administration | Aug 29, 2002 | Abandoned |
Array
(
[id] => 6656559
[patent_doc_number] => 20030009774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-09
[patent_title] => 'Screening systems and methods for identifying modulators of xenobiotic metabolism'
[patent_app_type] => new
[patent_app_number] => 10/219590
[patent_app_country] => US
[patent_app_date] => 2002-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8546
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20030009774.pdf
[firstpage_image] =>[orig_patent_app_number] => 10219590
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/219590 | Screening systems and methods for identifying modulators of xenobiotic metabolism | Aug 14, 2002 | Issued |
Array
(
[id] => 6791570
[patent_doc_number] => 20030086914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Method and device for inducing biological processes by micro-organs'
[patent_app_type] => new
[patent_app_number] => 10/193136
[patent_app_country] => US
[patent_app_date] => 2002-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 19851
[patent_no_of_claims] => 167
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20030086914.pdf
[firstpage_image] =>[orig_patent_app_number] => 10193136
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/193136 | Method and device for inducing biological processes by micro-organs | Jul 11, 2002 | Abandoned |